MED19 Knockdown Induces G1 Cell-Cycle Arrest Through Downregulation of AREG and CKS1B in Lung and Breast Cancer Cells
International Journal of Molecular Sciences · 08.11.2026 · 27 (21) · 10004
DOI: 10.3390/ijms272110004 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.11.2026. Verfasst von Sailakshmi Iyer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8523, Japan. Hauptthemen laut MEDLINE: CDC2-CDC28 Kinases, G1 Phase Cell Cycle Checkpoints, Lung Neoplasms, Breast Neoplasms. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Mediator complex subunit 19 (MED19), a component of the Mediator complex, has emerged as a potential regulator of cancer progression, although its downstream transcriptional programs remain poorly understood. Here, we investigated the role of MED19 across 20 human cancer cell lines. An siRNA-mediated knockdown (KD) screen identified A549 lung cancer and MCF-7 breast cancer cells as particularly sensitive to MED19 KD, exhibiting markedly reduced cell viability. Flow cytometric analysis revealed that MED19 KD induced G1-phase arrest, suggesting a role in G1/S-phase progression. RNA sequencing followed by differential expression, Gene Ontology (GO), and chromosomal mapping analyses identified amphiregulin (AREG) and cyclin-dependent kinase regulatory subunit 1B (CKS1B) as candidate downstream effectors in A549 and MCF-7 cells, respectively. Knockdown of AREG or CKS1B inhibited cell proliferation and recapitulated the G1-phase arrest induced by MED19 KD. Moreover, ectopic expression of AREG or CKS1B partially rescued the cell-cycle defects caused by MED19 KD. These findings identify MED19 as a context-dependent regulator of cancer cell proliferation and G1/S-phase progression through distinct downstream transcriptional programs in lung and breast cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8523, Japan.
- Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8523, Japan.
- Department of Bioscience and Bioinformatics, Kyushu Institute of Technology, Fukuoka 804-8550, Japan.
- Radiation Effects Research Foundation, Hiroshima 732-0815, Japan.
ORCID-Profile: Sailakshmi Iyer, Naoko Hattori, Takeya Nakagawa, Satoshi Fujii
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Iyer, S., Hattori, N., Nakagawa, T., Fujii, S., Hayashi, T., & Ito, T. (2026). MED19 Knockdown Induces G1 Cell-Cycle Arrest Through Downregulation of AREG and CKS1B in Lung and Breast Cancer Cells. International Journal of Molecular Sciences, 27(21), 10004. https://doi.org/10.3390/ijms272110004
Vancouver
Iyer S, Hattori N, Nakagawa T, Fujii S, Hayashi T, Ito T. MED19 Knockdown Induces G1 Cell-Cycle Arrest Through Downregulation of AREG and CKS1B in Lung and Breast Cancer Cells. International Journal of Molecular Sciences. 2026;27(21):10004. doi:10.3390/ijms272110004
BibTeX
@article{Iyer2026,
author = {Iyer, Sailakshmi and Hattori, Naoko and Nakagawa, Takeya and Fujii, Satoshi and Hayashi, Tomonori and Ito, Takashi},
title = {MED19 Knockdown Induces G1 Cell-Cycle Arrest Through Downregulation of AREG and CKS1B in Lung and Breast Cancer Cells},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {21},
pages = {10004},
doi = {10.3390/ijms272110004}
}
EUVIMED